SOURCE: StockCall

StockCall

October 28, 2011 08:00 ET

Analyst Research on Sequenom Inc. and Life Technologies Corporation -- Biotech Companies Succeeding in Bringing Products to the Global Marketplace

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Oct 28, 2011) - www.stockcall.com/ offers investors comprehensive research on the Biotechnology industry and has completed analytical research on Sequenom Inc. (NASDAQ: SQNM) and Life Technologies Corporation (NASDAQ: LIFE). Register with us today at www.stockcall.com/ to have free access to these researches.

Some companies in the Biotechnology Industry, such as Sequenom Inc. and Life Technologies Corp., have been garnering the attention of investors recently, as they have been able to successfully bring certain products to market both domestically and abroad. The long journey through various stages of approval can make or break companies that have spent countless hours and dollars on research and development. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Biotechnology industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Biotechnology industry can have easy and free access to our analyst research and opinions on Sequenom Inc. and Life Technologies Corporation; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

Sequenom recently announced that their Down syndrome prenatal test will be on the market in many U.S. cities after a delay of about two years. The test, which can be taken as early as 10 weeks into pregnancy, is designed to identify the genetic abnormality that is the main cause of Down syndrome. Investors looking for free research on Sequenom Inc. are welcome to sign up at www.stockcall.com/SQNM281011.pdf for our new report.

On the other hand, Life has also recently announced approval for one of its products for use in China. The company said that the State Food and Drug Administration of China had approved their genetic analyzer for diagnostic use. Investors looking for complimentary research on Life Technologies Corporation are welcome to sign up at www.stockcall.com/LIFE281011.pdf for our new report.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information